The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study

BACKGROUND: Randomized controlled trials (RCTs) have demonstrated a survival benefit for adjuvant platinum-based chemotherapy after resection of locoregional non-small cell lung cancer (NSCLC). The relative benefits and harms and optimal approach to treatment for NSCLC patients who have major comorb...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiter, Amanda, Kong, Chung Yin, Gould, Michael K., Kale, Minal S., Veluswamy, Rajwanth R., Smith, Cardinale B., Mhango, Grace, Huang, Brian Z., Wisnivesky, Juan P., Sigel, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665372/
https://www.ncbi.nlm.nih.gov/pubmed/36378625
http://dx.doi.org/10.1371/journal.pone.0263911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665372/
https://www.ncbi.nlm.nih.gov/pubmed/36378625
http://dx.doi.org/10.1371/journal.pone.0263911

Ejemplares similares